E-LIB Suche - Ergebnisse für: Borgå, Olof

1

Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel M..:

Borgå, Olof ; Henriksson, Roger ; Bjermo, Helena...
Advances in Therapy. 36 (2019) 5 - p. 1150-1163 , 2019

Link: https://doi.org/10.1007/..

2

Pharmacokinetics of Total and Unbound Paclitaxel After Admi..:

Borgå, Olof ; Lilienberg, Elsa ; Bjermo, Helena...
Advances in Therapy. 36 (2019) 10 - p. 2825-2837 , 2019

Link: https://doi.org/10.1007/..

3

Differentiating mucosal and hepatic metabolism of budesonid..:

Seidegård, Janeric ; Nyberg, Lars ; Borgå, Olof
European Journal of Pharmaceutical Sciences. 46 (2012) 5 - p. 530-536 , 2012

Link: https://doi.org/10.1016/..

4

Species differences in the plasma protein binding of desipr..:

Borgå, Olof ; Azarnoff, Daniel L ; Sjöqvist, Folke
Journal of Pharmacy and Pharmacology. 20 (2011) 7 - p. 571-572 , 2011

Link: https://doi.org/10.1111/..

5

Presystemic elimination of budesonide in man when administe..:

Seidegård, Janeric ; Nyberg, Lars ; Borgå, Olof
European Journal of Pharmaceutical Sciences. 35 (2008) 4 - p. 264-270 , 2008

Link: https://doi.org/10.1016/..

6

Active Renal Secretion of NXY‐059, a Novel Neuroprotectant,..:

Cheng, Yi‐Fang ; Strid, Stig ; Borgå, Olof..
The Journal of Clinical Pharmacology. 47 (2007) 7 - p. 909-914 , 2007

Link: https://doi.org/10.1177/..

7

A convenient method for local drug administration at predef..:

Nyberg, Lars ; Månsson, Wiking ; Abrahamsson, Bertil..
European Journal of Pharmaceutical Sciences. 30 (2007) 5 - p. 432-440 , 2007

Link: https://doi.org/10.1016/..

8

A Study of Organic Acid Transporter‐Mediated Pharmacokineti..:

Kågedal, Matts ; Nilsson, Dag ; Huledal, Gunilla...
The Journal of Clinical Pharmacology. 47 (2007) 8 - p. 1043-1048 , 2007

Link: https://doi.org/10.1177/..

9

NXY‐059 Does Not Significantly Interact With Furosemide in ..:

Strid, Stig ; Nilsson, Dag ; Borgå, Olof..
The Journal of Clinical Pharmacology. 46 (2006) 12 - p. 1417-1425 , 2006

Link: https://doi.org/10.1177/..

10

Pharmacokinetics and sedative effects in healthy subjects a..:

Centerholt, Carina ; Ekblom, Marianne ; Odergren, Tomas...
European Journal of Clinical Pharmacology. 59 (2003) 2 - p. 117-122 , 2003

Link: https://doi.org/10.1007/..

11

Pharmacokinetics of NXY-059, a nitrone-based free radical t..:

Edenius, Charlotte ; Strid, Stig ; Borgå, Olof...
Journal of Stroke and Cerebrovascular Diseases. 11 (2002) 1 - p. 34-42 , 2002

Link: https://doi.org/10.1053/..

12

Pharmacokinetics in renally impaired subjects of NXY-059, a..:

Strid, Stig ; Borgå, Olof ; Edenius, Charlotte...
European Journal of Clinical Pharmacology. 58 (2002) 6 - p. 409-415 , 2002

Link: https://doi.org/10.1007/..

13

The role of P-glycoprotein in limiting intestinal regional ..:

Sababi, Manaf ; Borgå, Olof ; Hultkvist-Bengtsson, Ursula
European Journal of Pharmaceutical Sciences. 14 (2001) 1 - p. 21-27 , 2001

Link: https://doi.org/10.1016/..

14

Distribution of Enprofylline and Theophylline Between Plasm..:

Laursen, Lars C. ; Borgå, Olof ; Krohn, Lisbeth.
Therapeutic Drug Monitoring. 11 (1989) 2 - p. 162-164 , 1989

Link: https://doi.org/10.1097/..

15

Transfer of Enprofylline into Breast Milk:

Laursen, Lars C. ; Borgå, Olof ; Ljungholm, Karin.
Therapeutic Drug Monitoring. 10 (1988) 2 - p. 150-152 , 1988

Link: https://doi.org/10.1097/..